Related Experiment Videos

Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma

Eda Erdogan1, Eric W Klee, E Aubrey Thompson

  • 1Department of Cancer Biology, Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|February 19, 2009
PubMed
Abstract

Insights

Atypical protein kinase C iota (PKCiota) drives lung cancer. Researchers identified four key genes regulated by PKCiota that promote tumor growth and invasion, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Atypical protein kinase C iota (PKCiota) is recognized as an oncogene in non-small cell lung cancer (NSCLC).
  • Lung adenocarcinoma (LAC) is the predominant subtype of NSCLC, making it a critical focus for oncogenic research.
  • Understanding the downstream targets of PKCiota is essential for elucidating its role in cancer progression.

Purpose of the Study:

  • To identify functional gene targets of PKCiota in lung adenocarcinoma (LAC).
  • To investigate the regulatory relationship between PKCiota and its target genes.
  • To determine the role of these target genes in LAC cell proliferation and invasion.

Main Methods:

  • Utilized meta-analysis of three independent public gene expression datasets to find genes co-expressed with PKCiota in LAC tumors.
  • Validated gene expression using quantitative PCR (QPCR) on an independent set of LAC samples.
  • Employed RNA interference (RNAi)-mediated knockdown to assess PKCiota's regulation of target genes and their functional impact on anchorage-independent growth and invasion.

Main Results:

  • Identified seven genes with expression correlating to PKCiota in LAC; four (COPB2, ELF3, RFC4, PLS1) were confirmed via QPCR.
  • Demonstrated that PKCiota regulates the expression of these four target genes in LAC cells.
  • Confirmed that the four PKCiota target genes are crucial for anchorage-independent growth and invasion in LAC cells.
  • Found that PKCiota target genes, notably COPB2 and RFC4, correlate with PKCiota expression across various cancer types.

Conclusions:

  • Meta-analysis of public gene expression data is effective for discovering novel oncogenic targets of PKCiota signaling.
  • The findings suggest that PKCiota-driven transformation involves both common and cell-type-specific signaling pathways.
  • Identified COPB2, ELF3, RFC4, and PLS1 as key downstream effectors of PKCiota in LAC, potentially serving as therapeutic targets.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...